Flint Rehab
Flint Rehab develops wearable technology and digital therapeutic solutions for neurological rehabilitation. The company creates devices and software that help patients recover motor function after stroke, traumatic brain injury, and other neurological conditions through engaging, gamified rehabilitation exercises. Flint Rehab's solutions combine evidence-based therapy protocols with motivational game design to…
Funding snapshot
About
Flint Rehab develops wearable technology and digital therapeutic solutions for neurological rehabilitation. The company creates devices and software that help patients recover motor function after stroke, traumatic brain injury, and other neurological conditions through engaging, gamified rehabilitation exercises. Flint Rehab's solutions combine evidence-based therapy protocols with motivational game design to improve patient adherence and outcomes, enabling continuous rehabilitation outside clinical settings. Founded in 2011, headquartered in Irvine, United States, The company has raised $8.0M at the Early Stage stage, backed by investors including NICHD, HHS, Profound Ventures. The company operates in the Life Sciences > Neurology, High Tech > Wearable Technology, Internet of Things - Industry Applications > Wearable Technology sector. with business models spanning Wearable Technology > Health and Wellness Devices > Rehabilitation > Internet First Brands, Neurology > Medical Devices > Therapeutic Devices > Stroke Rehabilitation. serving markets in United States. Developer of stroke rehabilitation systems..
Business model
Wearable Technology > Health and Wellness Devices > Rehabilitation > Internet First Brands,
Neurology > Medical Devices > Therapeutic Devices > Stroke Rehabilitation
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.